NCT05474963 Sudden Sensorineural Hearing Loss in Wonju Severance Christian Hospital
| NCT ID | NCT05474963 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Wonju Severance Christian Hospital |
| Condition | SSNHL(Sudden Sensory Neural Hearing Loss) |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2021-07-14 |
| Primary Completion | 2031-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2021-07-14 with a primary completion date of 2031-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is to build a cohort of sudden sensorineural hearing loss (SSNHL) patients. When the patient visited the Department of otolaryngology clinic for hearing loss, we can diagnose the SSNHL following the result of pure tone audiometry and the history of the patient. The cohort is a system that tracks the hearing recovery status, timing, and degree of recovery of patients who received cocktail therapy with or without high-dose steroids, vasodilators, antiviral agents, and intratympanic steroid injections, satellite ganglion block, and hyperbaric oxygen therapy.
Eligibility Criteria
Inclusion Criteria: * Adult patients over 20 years of age * A patient who visited Wonju Severance Christian Hospital, Department of Otolaryngology and was diagnosed with sudden hearing loss as it was confirmed that hearing loss of 30dBHL or more occurred within 3 days at three consecutive frequencies in a pure tone audiometry test. * Those who have fully explained the purpose and content of the study and voluntarily agreed to the written consent Exclusion Criteria: * If the patients do not want to or do not fill out the consent form * If treatment is started for sudden hearing loss, but the possibility of other inner ear diseases including Meniere's disease is suspected due to repeated hearing loss, repeated recovery, dizziness, tinnitus, etc. * Other cases where it is judged difficult to carry out the clinical trial due to the judgment of the person in charge of the above clinical trial
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05474963 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 100 Years, studying SSNHL(Sudden Sensory Neural Hearing Loss). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05474963 currently recruiting?
Yes, NCT05474963 is actively recruiting participants. Contact the research team at cochlear84@yonsei.ac.kr for enrollment information.
Where is the NCT05474963 trial being conducted?
This trial is being conducted at Wŏnju, South Korea.
Who is sponsoring the NCT05474963 clinical trial?
NCT05474963 is sponsored by Wonju Severance Christian Hospital. The trial plans to enroll 1,000 participants.